References

Amir LH Candida and the lactating breast: predisposing factors. J Human Lac. 1991; 7:(4)177-81

Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis. 2005; 40:(9)1258-62

Bardwell A, Hill DW, Runyon BA, Koster FT Disseminated macronodular cutaneous candidiasis in chronic alcoholism. Arch Intern Med. 1986; 146:(2)385-6

Breastfeeding Network. 2009. http://www.shb.scot.nhs.uk/departments/healthimprovement/documents/bfn-thrush2009.pdf (accessed 08 October 2014)

Brent NB Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment. Clin Pediatr (Phila). 2001; 40:503-6

British Association for Sexual Health and HIV. 2007. http://www.bashh.org/documents/50/50.pdf (accessed 10 October 2014)

Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1998; 78:(2)374-80

Crawford G, Sciacca J, James W Tea tree oil: cutaneous effects of the extracted oil of Melaleuca alternifolia. Dermatitis. 2004; 15:(2)59-66

Donders GG, Prenen H, Verbeke G, Reybrouck R Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am J Obstet Gynecol. 2002; 187:(4)989-93

Electronic Medicines Compendium. Summary of product characteristics for Canestan antifungal cream. 2013. http://www.medicines.org.uk/emc/medicine/6136/SPC/Canesten+Antifungal+Cream/ (accessed 10 October 2014)

The management of women of reproductive age attending non-genitourinary medicine settings complaining of vaginal discharge. J Fam Plan Reprod Health Care. 2006; 32:(1)33-41

Hay P, Czeizel AE Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007; 21:(3)403-9

Hilton E, Isenberg HD, Alperstein P, France K, Borenstein MT Ingestion of yoghurt containing lactobacillus-acidophilus as prophylaxix for candida vaginitis. Ann Intern Med. 1992; 116:(5)353-7

Hillier SL, Krohn MA, Rabe LK The normal vaginal flora, H2O2-producing lactobacilli and bacterial vaginosis in pregnant women. Clin Infect Dis. 1993; 16

Holland J, Young ML, Lee O, C-A Chen S Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect. 2003; 79:(3)249-50

Hong E, Dixit S, Bradford J, Fidel P, Fischer GO Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis. 2014; 18:(1)31-8

Hurley R, De Louvois J Candida vaginitis. Postgrad Med J. 1979; 55:645-7

Inman W, Pearce G, Wilton L Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy. Eur J Clin Pharmacol. 1994; 46:115-8

Jin Y, Samaranayake LP, Samaranayake Y, Yip HK Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol. 2004; 49:(10)789-98

London: BMJ Group and Pharmaceutical Press; 2014

National Institute for Health and Care Excellence. 2012. http://cks.nice.org.uk/candida-female-genital (accessed 01 September 2014)

Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother. 2008; 62:(1)172-6 https://doi.org/10.1093/jac/dkn157

Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis. 1996; 22:(2)336-40

Rhoads JL, Wright DC, Redfield RR, Burke DS Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA. 1987; 257:(22)3105-7

Treating vaginal candidiasis for the prevention of preterm birth: protocol for a systematic review and meta-analysis. Healthy start to life. 2014. http://ses.library.usyd.edu.au//bitstream/2123/11552/2/Roberts_CL_2014_Candida-preterm-birth_Systematic_Review_Protocol.pdf (accessed 09 October 2014)

Rosa MI, Silva BR, Pires PS, Silva FR, Silva NC, Silva FR, Souza SL, Madeira K, Panatto AP, Medeiros LR Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2013; 167:(2)132-6

Sharma M, Solanki A Prevalence of Candida infection in pregnant women with and without diabetes. Int J Curr Microbiol App Sci. 2014; 3:(4)605-10

Sobel JD Vulvovaginal candidosis. Lancet. 2007; 369:(9577)1961-71

Sobel JD, Subramanian C, Foxman B Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep. 2013; 15

UK Medicines Information. Can oral fluconazole be used during pregnancy?. 2012. http://www.medicinesresources.nhs.uk/upload/documents/Evidence/Medicines%20Q%20&%20A/NW%20QA147.4%20Fluconazole%20in%20pregnancy%202012.doc (accessed 09 October 2014)

Watson CJ, Pirotta M, Myers SP Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev. 2001; 4

Watson CJ, Pirotta M, Myers SP Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis—Results of a practitioner survey. Complement Ther Med. 2012; 20:(4)218-21 https://doi.org/10.1016/j.ctim.2012.01.004

Watson C, Calabretto H Comprehensive review of conventional and non-conventional methods of management of recurrent vulvovaginal candidiasis. Aust N Z J Obstet Gynaecol. 2007; 47:(4)262-72

Wilton L, Kollarova M, Heeley E, Shakir S Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England. Drug Saf. 2003; 26:(8)589-97

Topical treatment for vaginal candidiasis (thrush) in pregnancy. 2001. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000225/pdf/standard (accessed 09 October 2014)

Recurrent and persistent thrush in pregnancy

02 November 2014
8 min read
Volume 22 · Issue 11

Abstract

This article looks at the diagnosis and management of recurrent vulvovaginal candidiasis (RVVC) in non-pregnant and pregnant women. This is a distressing condition that can cause a variety of different symptoms, including preterm labour. Although it is a commonly occurring infection in up to 40% of pregnant women, it should not be treated lightly. There is a range of anti-fungal medications although some cannot be used in pregnancy. This article is a helpful reminder of what can be prescribed.

One of the most common causes of yeast infections in the vulvovaginal area is Candida albicans (Holland et al, 2003; Sobel et al, 2013). During their childbearing years, 75% of women will experience at least one episode of vulvovaginal candidiasis (Hurley and De Louvois, 1979) and about 5–8% of these women will have recurrent vulvovaginal candidiasis (RVVC) at least once during their lives (Hurley and De Louvois, 1979; Sobel, 2007). However, 10–20% of women may be colonised with Candida but be asymptomatic (British Association for Sexual Health and HIV (BASHH), 2007). Vulvovaginal candidiasis can be found in 40% of healthy pregnant women (Hay and Czeizel, 2007). With these high numbers it is important to consider the impact that candidiasis can have on the pregnant mother or baby.

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • Unlimited access to the latest news, blogs and video content

  • Monthly email newsletter